EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tumor‐Intrinsic ARHGEF3 Enhances Antitumor Immunity by Promoting T‐Cell Infiltration and Limiting Myeloid Cell‐Mediated Immunosuppression

Yue Li, Lan Wang, Zihao Zhang, Chunmei Qian, Ning Li, Wei Huang, Qian Ba, Xiaojian Liu, Mayu Sun iD

Advanced Science · 2026-07 · 13 (38)

DOI: 10.1002/advs.202523895 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 23.04.2026. Verfasst von Yue Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Science and Technology Innovation Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Med…. Hauptthemen laut MEDLINE: Rho Guanine Nucleotide Exchange Factors, T-Lymphocytes, Tumor Microenvironment, Myeloid Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Sailing Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A lack of effective antitumor T‐cell immunity often drives immune evasion and immunotherapy resistance. Here, we demonstrated that tumor‐intrinsic ARHGEF3 reprogrammed the tumor microenvironment into a T‐cell‐inflamed state, resulting in potent antitumor effects. Mechanistically, ARHGEF3 functioned as a guanine nucleotide exchange factor that activated the RHOA‐ROCK‐PTEN cascade and inhibited AKT signaling. This inhibition upregulated IRF1‐dependent chemokines CXCL10 and CXCL11 to drive T‐cell infiltration, while suppressing FASN‐mediated fatty acid synthesis to limit myeloid cell‐mediated immunosuppression. The dual effects elicited robust T‐cell immunity and overcame tumor resistance to immunotherapy. In human tumors, ARHGEF3 expression correlated positively with T‐cell‐inflamed signatures, improved clinical outcomes, and responsiveness to immunotherapy. Collectively, these findings identify ARHGEF3 as a key modulator linking chemokine signaling with lipid availability to shape T‐cell immunity, offering a promising therapeutic strategy to overcome immunotherapy resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rho Guanine Nucleotide Exchange FactorsT-LymphocytesTumor MicroenvironmentMyeloid CellsNeoplasmsHumansAnimalsMiceSignal Transduction

Stichwörter der Autor:innen

ARHGEF3T‐cell infiltrationfatty acid metabolismmyeloid cell‐mediated immunosuppressiontumor microenvironment

Substanzen

Rho Guanine Nucleotide Exchange FactorsARHGEF3 protein, human

Autor:innen und Institutionen

  • Science and Technology Innovation Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • The Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing, China.
  • CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.
  • Department of Pharmacy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
  • Institute of Image Processing and Pattern Recognition, Key Laboratory of System Control and Information Processing, Ministry of Education of China, Shanghai Jiao Tong University, Shanghai, China.

ORCID-Profile: Mayu Sun

Förderung

  • National Natural Science Foundation of China
  • Shanghai Sailing Program

Zitieren

APA

Li, Y., Wang, L., Zhang, Z., Qian, C., Li, N., Huang, W., Ba, Q., Liu, X., & Sun, M. (2026). Tumor‐Intrinsic ARHGEF3 Enhances Antitumor Immunity by Promoting T‐Cell Infiltration and Limiting Myeloid Cell‐Mediated Immunosuppression. Advanced Science, 13(38). https://doi.org/10.1002/advs.202523895

Vancouver

Li Y, Wang L, Zhang Z, Qian C, Li N, Huang W, et al. Tumor‐Intrinsic ARHGEF3 Enhances Antitumor Immunity by Promoting T‐Cell Infiltration and Limiting Myeloid Cell‐Mediated Immunosuppression. Advanced Science. 2026;13(38). doi:10.1002/advs.202523895

BibTeX
@article{Li2026,
  author = {Li, Yue and Wang, Lan and Zhang, Zihao and Qian, Chunmei and Li, Ning and Huang, Wei and Ba, Qian and Liu, Xiaojian and Sun, Mayu},
  title = {Tumor‐Intrinsic ARHGEF3 Enhances Antitumor Immunity by Promoting T‐Cell Infiltration and Limiting Myeloid Cell‐Mediated Immunosuppression},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {38},
  doi = {10.1002/advs.202523895}
}
Kostenlos starten →